Ronnie Willenheimer (Former)
1 – 20 of 101
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Association of Annual N-Terminal Pro-Brain Natriuretic Peptide Measurements with Clinical Events in Patients with Asymptomatic Nonsevere Aortic Stenosis : A Post Hoc Substudy of the SEAS Trial
(
- Contribution to journal › Article
- 2019
-
Mark
The Association between Serum Testosterone and Risk Factors for Atherosclerosis
(
- Contribution to journal › Article
- 2016
-
Mark
Association between Erectile Function and Biomarkers of Subclinical Atherosclerosis : A Study Based on Middle-Aged Healthy Men from the General Population
(
- Contribution to journal › Article
-
Mark
Assessing optimal blood pressure in patients with asymptomatic aortic valve stenosis
(
- Contribution to journal › Article
- 2015
-
Mark
High sensitivity C reactive protein as a prognostic marker in patients with mild to moderate aortic valve stenosis during lipid-lowering treatment: an SEAS substudy.
(
- Contribution to journal › Article
-
Mark
The impact of intravenous ferric carboxymaltose on renal function: an analysis of the FAIR-HF study
(
- Contribution to journal › Article
- 2014
-
Mark
Indexing aortic valve area by body surface area increases the prevalence of severe aortic stenosis
(
- Contribution to journal › Article
-
Mark
Incidence of Cancer and Mortality in Patients from the Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) Trial.
(
- Contribution to journal › Article
-
Mark
Adjusting parameters of aortic valve stenosis severity by body size
(
- Contribution to journal › Article
-
Mark
Extracellular Matrix Biomarker, Fibulin-1, Is Closely Related to NT-proBNP and Soluble Urokinase Plasminogen Activator Receptor in Patients with Aortic Valve Stenosis (The SEAS Study).
(
- Contribution to journal › Article
- 2013
-
Mark
The effect of intravenous ferric carboxymaltose on health-related quality of life in patients with chronic heart failure and iron deficiency: a subanalysis of the FAIR-HF study
(
- Contribution to journal › Article
-
Mark
Intravenous ferric carboxymaltose in iron-deficient chronic heart failure patients with and without anaemia: a subanalysis of the FAIR-HF trial
(
- Contribution to journal › Article
-
Mark
Prognostic importance of atrial fibrillation in asymptomatic aortic stenosis: The Simvastatin and Ezetimibe in Aortic Stenosis study
(
- Contribution to journal › Article
-
Mark
Mitral annular plane systolic excursion (MAPSE) in shock: a valuable echocardiographic parameter in intensive care patients
(
- Contribution to journal › Article
- 2012
-
Mark
Aortic stenosis and mitral regurgitation as predictors of atrial fibrillation during 11 years of follow-up
(
- Contribution to journal › Article
-
Mark
Clinical Implications of Electrocardiographic Left Ventricular Strain and Hypertrophy in Asymptomatic Patients With Aortic Stenosis The Simvastatin and Ezetimibe in Aortic Stenosis Study
(
- Contribution to journal › Article
-
Mark
A risk score for predicting mortality in patients with asymptomatic mild to moderate aortic stenosis
(
- Contribution to journal › Article
-
Mark
High-sensitive cardiac Troponin T is superior to echocardiography in predicting 1-year mortality in patients with SIRS and shock in intensive care
(
- Contribution to journal › Article
-
Mark
Impact of QRS Duration and Morphology on the Risk of Sudden Cardiac Death in Asymptomatic Patients With Aortic Stenosis The SEAS (Simvastatin and Ezetimibe in Aortic Stenosis) Study
(
- Contribution to journal › Article
- 2011
-
Mark
The association between glucometabolic disturbances, traditional cardiovascular risk factors and self-rated health by age and gender: A cross-sectional analysis within the Malmo Preventive Project
(
- Contribution to journal › Article